IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 95 filers reported holding IGM BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $295,256 | -2.4% | 35,360 | +7.9% | 0.00% | – |
| Q2 2023 | $302,467 | -15.0% | 32,770 | +26.5% | 0.00% | – |
| Q1 2023 | $355,866 | -19.2% | 25,900 | 0.0% | 0.00% | – |
| Q4 2022 | $440,559 | -20.2% | 25,900 | +6.6% | 0.00% | – |
| Q3 2022 | $552,000 | +22.9% | 24,296 | -2.4% | 0.00% | – |
| Q2 2022 | $449,000 | +12.0% | 24,900 | +66.0% | 0.00% | – |
| Q1 2022 | $401,000 | -8.9% | 15,000 | 0.0% | 0.00% | – |
| Q4 2021 | $440,000 | -55.4% | 15,000 | 0.0% | 0.00% | – |
| Q3 2021 | $986,000 | -23.6% | 15,000 | -3.2% | 0.00% | -100.0% |
| Q2 2021 | $1,290,000 | +40.2% | 15,500 | +29.2% | 0.00% | – |
| Q1 2021 | $920,000 | -19.9% | 12,000 | -7.7% | 0.00% | -100.0% |
| Q4 2020 | $1,148,000 | +18.7% | 13,000 | -0.8% | 0.00% | 0.0% |
| Q3 2020 | $967,000 | +20.4% | 13,100 | +19.1% | 0.00% | – |
| Q2 2020 | $803,000 | +72.3% | 11,000 | +32.5% | 0.00% | – |
| Q1 2020 | $466,000 | – | 8,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 3,334,355 | $75,823,000 | 2.94% |
| Artal Group S.A. | 2,450,000 | $55,713,000 | 2.38% |
| Samsara BioCapital, LLC | 154,664 | $3,517,000 | 0.82% |
| Eagle Bay Advisors LLC | 41,635 | $947,000 | 0.58% |
| Baker Brothers Advisors | 3,156,102 | $71,770,000 | 0.47% |
| Bruce & Co., Inc. | 55,000 | $1,250,000 | 0.34% |
| Corton Capital Inc. | 9,999 | $227,000 | 0.28% |
| Delphia (USA) Inc. | 10,185 | $232,000 | 0.26% |
| Alkeon Capital Management | 961,613 | $21,867,000 | 0.07% |
| Virtus ETF Advisers LLC | 7,319 | $166,000 | 0.07% |